0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global PET Isotope Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-33L16908
Home | Market Reports | Business & Industrial| Chemicals Industry
Global PET Isotope Market Research Report 2024
BUY CHAPTERS

Global PET Isotope Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-33L16908
Report
November 2025
Pages:145
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

PET Isotope Market

The global PET Isotope market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Hospitals & Clinics accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
PET Isotope leading manufacturers including IBA - Radio Pharma Solutions, ANSTO, Cambridge Isotope Laboratories, Eckert & Ziegler, ROSATOM, Siemens Healthineers, GE Healthcare, TRIUMF, etc., dominate supply; the top five capture approximately % of global revenue, with IBA - Radio Pharma Solutions leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global PET Isotope market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of PET Isotope Market Report

Report Metric Details
Report Name PET Isotope Market
Segment by Type
  • Carbon 11
  • Nitrogen 13
  • Oxygen 15
  • Fluorine 18
  • Others
Segment by Application
  • Hospitals & Clinics
  • Research Institutions
Production by Region
  • North America
  • Europe
  • China
  • Japan
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company IBA - Radio Pharma Solutions, ANSTO, Cambridge Isotope Laboratories, Eckert & Ziegler, ROSATOM, Siemens Healthineers, GE Healthcare, TRIUMF
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the PET Isotope study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
  • Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
  • Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the PET Isotope Market report?

Ans: The main players in the PET Isotope Market are IBA - Radio Pharma Solutions, ANSTO, Cambridge Isotope Laboratories, Eckert & Ziegler, ROSATOM, Siemens Healthineers, GE Healthcare, TRIUMF

What are the Application segmentation covered in the PET Isotope Market report?

Ans: The Applications covered in the PET Isotope Market report are Hospitals & Clinics, Research Institutions

What are the Type segmentation covered in the PET Isotope Market report?

Ans: The Types covered in the PET Isotope Market report are Carbon 11, Nitrogen 13, Oxygen 15, Fluorine 18, Others

1 Study Coverage
1.1 Introduction to PET Isotope: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global PET Isotope Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Carbon 11
1.2.3 Nitrogen 13
1.2.4 Oxygen 15
1.2.5 Fluorine 18
1.2.6 Others
1.3 Market Segmentation by Application
1.3.1 Global PET Isotope Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals & Clinics
1.3.3 Research Institutions
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global PET Isotope Revenue Estimates and Forecasts 2020-2031
2.2 Global PET Isotope Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global PET Isotope Sales Estimates and Forecasts 2020-2031
2.4 Global PET Isotope Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global PET Isotope Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global PET Isotope Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global PET Isotope Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Carbon 11 Market Size by Manufacturers
4.5.2 Nitrogen 13 Market Size by Manufacturers
4.5.3 Oxygen 15 Market Size by Manufacturers
4.5.4 Fluorine 18 Market Size by Manufacturers
4.5.5 Others Market Size by Manufacturers
4.6 Global PET Isotope Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global PET Isotope Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global PET Isotope Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global PET Isotope Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global PET Isotope Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America PET Isotope Sales and Revenue by Type (2020-2031)
7.4 North America PET Isotope Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America PET Isotope Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe PET Isotope Sales and Revenue by Type (2020-2031)
8.4 Europe PET Isotope Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe PET Isotope Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific PET Isotope Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific PET Isotope Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific PET Isotope Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America PET Isotope Sales and Revenue by Type (2020-2031)
10.4 Central and South America PET Isotope Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America PET Isotope Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa PET Isotope Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa PET Isotope Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa PET Isotope Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 IBA - Radio Pharma Solutions
12.1.1 IBA - Radio Pharma Solutions Corporation Information
12.1.2 IBA - Radio Pharma Solutions Business Overview
12.1.3 IBA - Radio Pharma Solutions PET Isotope Product Models, Descriptions and Specifications
12.1.4 IBA - Radio Pharma Solutions PET Isotope Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 IBA - Radio Pharma Solutions PET Isotope Sales by Product in 2024
12.1.6 IBA - Radio Pharma Solutions PET Isotope Sales by Application in 2024
12.1.7 IBA - Radio Pharma Solutions PET Isotope Sales by Geographic Area in 2024
12.1.8 IBA - Radio Pharma Solutions PET Isotope SWOT Analysis
12.1.9 IBA - Radio Pharma Solutions Recent Developments
12.2 ANSTO
12.2.1 ANSTO Corporation Information
12.2.2 ANSTO Business Overview
12.2.3 ANSTO PET Isotope Product Models, Descriptions and Specifications
12.2.4 ANSTO PET Isotope Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 ANSTO PET Isotope Sales by Product in 2024
12.2.6 ANSTO PET Isotope Sales by Application in 2024
12.2.7 ANSTO PET Isotope Sales by Geographic Area in 2024
12.2.8 ANSTO PET Isotope SWOT Analysis
12.2.9 ANSTO Recent Developments
12.3 Cambridge Isotope Laboratories
12.3.1 Cambridge Isotope Laboratories Corporation Information
12.3.2 Cambridge Isotope Laboratories Business Overview
12.3.3 Cambridge Isotope Laboratories PET Isotope Product Models, Descriptions and Specifications
12.3.4 Cambridge Isotope Laboratories PET Isotope Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Cambridge Isotope Laboratories PET Isotope Sales by Product in 2024
12.3.6 Cambridge Isotope Laboratories PET Isotope Sales by Application in 2024
12.3.7 Cambridge Isotope Laboratories PET Isotope Sales by Geographic Area in 2024
12.3.8 Cambridge Isotope Laboratories PET Isotope SWOT Analysis
12.3.9 Cambridge Isotope Laboratories Recent Developments
12.4 Eckert & Ziegler
12.4.1 Eckert & Ziegler Corporation Information
12.4.2 Eckert & Ziegler Business Overview
12.4.3 Eckert & Ziegler PET Isotope Product Models, Descriptions and Specifications
12.4.4 Eckert & Ziegler PET Isotope Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Eckert & Ziegler PET Isotope Sales by Product in 2024
12.4.6 Eckert & Ziegler PET Isotope Sales by Application in 2024
12.4.7 Eckert & Ziegler PET Isotope Sales by Geographic Area in 2024
12.4.8 Eckert & Ziegler PET Isotope SWOT Analysis
12.4.9 Eckert & Ziegler Recent Developments
12.5 ROSATOM
12.5.1 ROSATOM Corporation Information
12.5.2 ROSATOM Business Overview
12.5.3 ROSATOM PET Isotope Product Models, Descriptions and Specifications
12.5.4 ROSATOM PET Isotope Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 ROSATOM PET Isotope Sales by Product in 2024
12.5.6 ROSATOM PET Isotope Sales by Application in 2024
12.5.7 ROSATOM PET Isotope Sales by Geographic Area in 2024
12.5.8 ROSATOM PET Isotope SWOT Analysis
12.5.9 ROSATOM Recent Developments
12.6 Siemens Healthineers
12.6.1 Siemens Healthineers Corporation Information
12.6.2 Siemens Healthineers Business Overview
12.6.3 Siemens Healthineers PET Isotope Product Models, Descriptions and Specifications
12.6.4 Siemens Healthineers PET Isotope Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Siemens Healthineers Recent Developments
12.7 GE Healthcare
12.7.1 GE Healthcare Corporation Information
12.7.2 GE Healthcare Business Overview
12.7.3 GE Healthcare PET Isotope Product Models, Descriptions and Specifications
12.7.4 GE Healthcare PET Isotope Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 GE Healthcare Recent Developments
12.8 TRIUMF
12.8.1 TRIUMF Corporation Information
12.8.2 TRIUMF Business Overview
12.8.3 TRIUMF PET Isotope Product Models, Descriptions and Specifications
12.8.4 TRIUMF PET Isotope Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 TRIUMF Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 PET Isotope Industry Chain
13.2 PET Isotope Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 PET Isotope Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 PET Isotope Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 PET Isotope Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global PET Isotope Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
List of Tables
 Table 1. Global PET Isotope Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global PET Isotope Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global PET Isotope Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global PET Isotope Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global PET Isotope Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global PET Isotope Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (mCi)
 Table 7. Global PET Isotope Sales by Region (2020-2025) & (mCi)
 Table 8. Global PET Isotope Sales by Region (2026-2031) & (mCi)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global PET Isotope Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (mCi)
 Table 11. Global PET Isotope Production by Region (2020-2025) & (mCi)
 Table 12. Global PET Isotope Production by Region (2026-2031) & (mCi)
 Table 13. Global PET Isotope Sales by Manufacturers (2020-2025) & (mCi)
 Table 14. Global PET Isotope Sales Share by Manufacturers (2020-2025)
 Table 15. Global PET Isotope Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 16. Global PET Isotope Revenue Market Share by Manufacturers (2020-2025)
 Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 18. Global PET Isotope by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PET Isotope as of 2024)
 Table 19. Global PET Isotope Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 20. Global PET Isotope Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/mCi)
 Table 21. Key Manufacturers PET Isotope Manufacturing Base and Headquarters
 Table 22. Global PET Isotope Market Concentration Ratio (CR5 and HHI)
 Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 25. Global PET Isotope Sales by Type (2020-2025) & (mCi)
 Table 26. Global PET Isotope Sales by Type (2026-2031) & (mCi)
 Table 27. Global PET Isotope Revenue by Type (2020-2025) & (US$ Million)
 Table 28. Global PET Isotope Revenue by Type (2026-2031) & (US$ Million)
 Table 29. Global PET Isotope ASP by Type (2020-2031) & (US$/mCi)
 Table 30. Technical Specifications by Key Product Type
 Table 31. Global PET Isotope Sales by Application (2020-2025) & (mCi)
 Table 32. Global PET Isotope Sales by Application (2026-2031) & (mCi)
 Table 33. PET Isotope High-Growth Sectors Demand CAGR (2024-2031)
 Table 34. Global PET Isotope Revenue by Application (2020-2025) & (US$ Million)
 Table 35. Global PET Isotope Revenue by Application (2026-2031) & (US$ Million)
 Table 36. Global PET Isotope ASP by Application (2020-2031) & (US$/mCi)
 Table 37. Top Customers by Region
 Table 38. Top Customers by Application
 Table 39. North America PET Isotope Growth Accelerators and Market Barriers
 Table 40. North America PET Isotope Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 41. North America PET Isotope Sales (mCi) by Country (2020 VS 2024 VS 2031)
 Table 42. Europe PET Isotope Growth Accelerators and Market Barriers
 Table 43. Europe PET Isotope Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 44. Europe PET Isotope Sales (mCi) by Country (2020 VS 2024 VS 2031)
 Table 45. Asia-Pacific PET Isotope Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Asia-Pacific PET Isotope Sales (mCi) by Country (2020 VS 2024 VS 2031)
 Table 47. Asia-Pacific PET Isotope Growth Accelerators and Market Barriers
 Table 48. Southeast Asia PET Isotope Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 49. Central and South America PET Isotope Investment Opportunities and Key Challenges
 Table 50. Central and South America PET Isotope Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 51. Middle East and Africa PET Isotope Investment Opportunities and Key Challenges
 Table 52. Middle East and Africa PET Isotope Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 53. IBA - Radio Pharma Solutions Corporation Information
 Table 54. IBA - Radio Pharma Solutions Description and Major Businesses
 Table 55. IBA - Radio Pharma Solutions Product Models, Descriptions and Specifications
 Table 56. IBA - Radio Pharma Solutions Capacity, Sales (mCi), Revenue (US$ Million), Price (US$/mCi) and Gross Margin (2020-2025)
 Table 57. IBA - Radio Pharma Solutions Sales Value Proportion by Product in 2024
 Table 58. IBA - Radio Pharma Solutions Sales Value Proportion by Application in 2024
 Table 59. IBA - Radio Pharma Solutions Sales Value Proportion by Geographic Area in 2024
 Table 60. IBA - Radio Pharma Solutions PET Isotope SWOT Analysis
 Table 61. IBA - Radio Pharma Solutions Recent Developments
 Table 62. ANSTO Corporation Information
 Table 63. ANSTO Description and Major Businesses
 Table 64. ANSTO Product Models, Descriptions and Specifications
 Table 65. ANSTO Capacity, Sales (mCi), Revenue (US$ Million), Price (US$/mCi) and Gross Margin (2020-2025)
 Table 66. ANSTO Sales Value Proportion by Product in 2024
 Table 67. ANSTO Sales Value Proportion by Application in 2024
 Table 68. ANSTO Sales Value Proportion by Geographic Area in 2024
 Table 69. ANSTO PET Isotope SWOT Analysis
 Table 70. ANSTO Recent Developments
 Table 71. Cambridge Isotope Laboratories Corporation Information
 Table 72. Cambridge Isotope Laboratories Description and Major Businesses
 Table 73. Cambridge Isotope Laboratories Product Models, Descriptions and Specifications
 Table 74. Cambridge Isotope Laboratories Capacity, Sales (mCi), Revenue (US$ Million), Price (US$/mCi) and Gross Margin (2020-2025)
 Table 75. Cambridge Isotope Laboratories Sales Value Proportion by Product in 2024
 Table 76. Cambridge Isotope Laboratories Sales Value Proportion by Application in 2024
 Table 77. Cambridge Isotope Laboratories Sales Value Proportion by Geographic Area in 2024
 Table 78. Cambridge Isotope Laboratories PET Isotope SWOT Analysis
 Table 79. Cambridge Isotope Laboratories Recent Developments
 Table 80. Eckert & Ziegler Corporation Information
 Table 81. Eckert & Ziegler Description and Major Businesses
 Table 82. Eckert & Ziegler Product Models, Descriptions and Specifications
 Table 83. Eckert & Ziegler Capacity, Sales (mCi), Revenue (US$ Million), Price (US$/mCi) and Gross Margin (2020-2025)
 Table 84. Eckert & Ziegler Sales Value Proportion by Product in 2024
 Table 85. Eckert & Ziegler Sales Value Proportion by Application in 2024
 Table 86. Eckert & Ziegler Sales Value Proportion by Geographic Area in 2024
 Table 87. Eckert & Ziegler PET Isotope SWOT Analysis
 Table 88. Eckert & Ziegler Recent Developments
 Table 89. ROSATOM Corporation Information
 Table 90. ROSATOM Description and Major Businesses
 Table 91. ROSATOM Product Models, Descriptions and Specifications
 Table 92. ROSATOM Capacity, Sales (mCi), Revenue (US$ Million), Price (US$/mCi) and Gross Margin (2020-2025)
 Table 93. ROSATOM Sales Value Proportion by Product in 2024
 Table 94. ROSATOM Sales Value Proportion by Application in 2024
 Table 95. ROSATOM Sales Value Proportion by Geographic Area in 2024
 Table 96. ROSATOM PET Isotope SWOT Analysis
 Table 97. ROSATOM Recent Developments
 Table 98. Siemens Healthineers Corporation Information
 Table 99. Siemens Healthineers Description and Major Businesses
 Table 100. Siemens Healthineers Product Models, Descriptions and Specifications
 Table 101. Siemens Healthineers Capacity, Sales (mCi), Revenue (US$ Million), Price (US$/mCi) and Gross Margin (2020-2025)
 Table 102. Siemens Healthineers Recent Developments
 Table 103. GE Healthcare Corporation Information
 Table 104. GE Healthcare Description and Major Businesses
 Table 105. GE Healthcare Product Models, Descriptions and Specifications
 Table 106. GE Healthcare Capacity, Sales (mCi), Revenue (US$ Million), Price (US$/mCi) and Gross Margin (2020-2025)
 Table 107. GE Healthcare Recent Developments
 Table 108. TRIUMF Corporation Information
 Table 109. TRIUMF Description and Major Businesses
 Table 110. TRIUMF Product Models, Descriptions and Specifications
 Table 111. TRIUMF Capacity, Sales (mCi), Revenue (US$ Million), Price (US$/mCi) and Gross Margin (2020-2025)
 Table 112. TRIUMF Recent Developments
 Table 113. Key Raw Materials Distribution
 Table 114. Raw Materials Key Suppliers
 Table 115. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 116. Milestones in Production Technology Evolution
 Table 117. Distributors List
 Table 118. Market Trends and Market Evolution
 Table 119. Market Drivers and Opportunities
 Table 120. Market Challenges, Risks, and Restraints
 Table 121. Research Programs/Design for This Report
 Table 122. Key Data Information from Secondary Sources
 Table 123. Key Data Information from Primary Sources


List of Figures
 Figure 1. PET Isotope Product Picture
 Figure 2. Global PET Isotope Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Carbon 11 Product Picture
 Figure 4. Nitrogen 13 Product Picture
 Figure 5. Oxygen 15 Product Picture
 Figure 6. Fluorine 18 Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global PET Isotope Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 9. Hospitals & Clinics
 Figure 10. Research Institutions
 Figure 11. PET Isotope Report Years Considered
 Figure 12. Global PET Isotope Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global PET Isotope Revenue (2020-2031) & (US$ Million)
 Figure 14. Global PET Isotope Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 15. Global PET Isotope Revenue Market Share by Region (2020-2031)
 Figure 16. Global PET Isotope Sales (2020-2031) & (mCi)
 Figure 17. Global PET Isotope Sales (CAGR) by Region (2020-2031) (mCi)
 Figure 18. Global PET Isotope Sales Market Share by Region (2020-2031)
 Figure 19. Global PET Isotope Capacity, Production and Utilization (2020-2031) & (mCi)
 Figure 20. Global PET Isotope Production Trend by Region (2020-2031) (mCi)
 Figure 21. Global PET Isotope Production Market Share by Region (2020-2031)
 Figure 22. Production Capacity Enablers & Constraints
 Figure 23. PET Isotope Production Growth Rate in North America (2020-2031) & (mCi)
 Figure 24. PET Isotope Production Growth Rate in Europe (2020-2031) & (mCi)
 Figure 25. PET Isotope Production Growth Rate in China (2020-2031) & (mCi)
 Figure 26. PET Isotope Production Growth Rate in Japan (2020-2031) & (mCi)
 Figure 27. Top 5 and Top 10 Manufacturers PET Isotope Sales Volume Market Share in 2024
 Figure 28. Global PET Isotope Revenue Market Share Ranking (2024)
 Figure 29. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 30. Carbon 11 Revenue Market Share by Manufacturer in 2024
 Figure 31. Nitrogen 13 Revenue Market Share by Manufacturer in 2024
 Figure 32. Oxygen 15 Revenue Market Share by Manufacturer in 2024
 Figure 33. Fluorine 18 Revenue Market Share by Manufacturer in 2024
 Figure 34. Others Revenue Market Share by Manufacturer in 2024
 Figure 35. Type Eight Revenue Market Share by Manufacturer in 2024
 Figure 36. Type Nine Revenue Market Share by Manufacturer in 2024
 Figure 37. Global PET Isotope Sales Market Share by Type (2020-2031)
 Figure 38. Global PET Isotope Revenue Market Share by Type (2020-2031)
 Figure 39. Global PET Isotope Sales Market Share by Application (2020-2031)
 Figure 40. Global PET Isotope Revenue Market Share by Application (2020-2031)
 Figure 41. North America PET Isotope Sales YoY (2020-2031) & (mCi)
 Figure 42. North America PET Isotope Revenue YoY (2020-2031) & (US$ Million)
 Figure 43. North America Top 5 Manufacturers PET Isotope Sales Revenue (US$ Million) in 2024
 Figure 44. North America PET Isotope Sales Volume (mCi) by Type (2020- 2031)
 Figure 45. North America PET Isotope Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 46. North America PET Isotope Sales Volume (mCi) by Application (2020-2031)
 Figure 47. North America PET Isotope Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 48. US PET Isotope Revenue (2020-2031) & (US$ Million)
 Figure 49. Canada PET Isotope Revenue (2020-2031) & (US$ Million)
 Figure 50. Mexico PET Isotope Revenue (2020-2031) & (US$ Million)
 Figure 51. Europe PET Isotope Sales YoY (2020-2031) & (mCi)
 Figure 52. Europe PET Isotope Revenue YoY (2020-2031) & (US$ Million)
 Figure 53. Europe Top 5 Manufacturers PET Isotope Sales Revenue (US$ Million) in 2024
 Figure 54. Europe PET Isotope Sales Volume (mCi) by Type (2020-2031)
 Figure 55. Europe PET Isotope Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 56. Europe PET Isotope Sales Volume (mCi) by Application (2020-2031)
 Figure 57. Europe PET Isotope Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 58. Germany PET Isotope Revenue (2020-2031) & (US$ Million)
 Figure 59. France PET Isotope Revenue (2020-2031) & (US$ Million)
 Figure 60. U.K. PET Isotope Revenue (2020-2031) & (US$ Million)
 Figure 61. Italy PET Isotope Revenue (2020-2031) & (US$ Million)
 Figure 62. Russia PET Isotope Revenue (2020-2031) & (US$ Million)
 Figure 63. Asia-Pacific PET Isotope Sales YoY (2020-2031) & (mCi)
 Figure 64. Asia-Pacific PET Isotope Revenue YoY (2020-2031) & (US$ Million)
 Figure 65. Asia-Pacific Top 8 Manufacturers PET Isotope Sales Revenue (US$ Million) in 2024
 Figure 66. Asia-Pacific PET Isotope Sales Volume (mCi) by Type (2020- 2031)
 Figure 67. Asia-Pacific PET Isotope Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 68. Asia-Pacific PET Isotope Sales Volume (mCi) by Application (2020-2031)
 Figure 69. Asia-Pacific PET Isotope Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 70. Indonesia PET Isotope Revenue (2020-2031) & (US$ Million)
 Figure 71. Japan PET Isotope Revenue (2020-2031) & (US$ Million)
 Figure 72. South Korea PET Isotope Revenue (2020-2031) & (US$ Million)
 Figure 73. China Taiwan PET Isotope Revenue (2020-2031) & (US$ Million)
 Figure 74. India PET Isotope Revenue (2020-2031) & (US$ Million)
 Figure 75. Central and South America PET Isotope Sales YoY (2020-2031) & (mCi)
 Figure 76. Central and South America PET Isotope Revenue YoY (2020-2031) & (US$ Million)
 Figure 77. Central and South America Top 5 Manufacturers PET Isotope Sales Revenue (US$ Million) in 2024
 Figure 78. Central and South America PET Isotope Sales Volume (mCi) by Type (2021-2031)
 Figure 79. Central and South America PET Isotope Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 80. Central and South America PET Isotope Sales Volume (mCi) by Application (2020-2031)
 Figure 81. Central and South America PET Isotope Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 82. Brazil PET Isotope Revenue (2020-2025) & (US$ Million)
 Figure 83. Argentina PET Isotope Revenue (2020-2025) & (US$ Million)
 Figure 84. Middle East, and Africa PET Isotope Sales YoY (2020-2031) & (mCi)
 Figure 85. Middle East and Africa PET Isotope Revenue YoY (2020-2031) & (US$ Million)
 Figure 86. Middle East and Africa Top 5 Manufacturers PET Isotope Sales Revenue (US$ Million) in 2024
 Figure 87. Middle East and Africa PET Isotope Sales Volume (mCi) by Type (2021-2031)
 Figure 88. South America PET Isotope Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 89. Middle East and Africa PET Isotope Sales Volume (mCi) by Application (2020-2031)
 Figure 90. Middle East and Africa PET Isotope Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 91. GCC Countries PET Isotope Revenue (2020-2025) & (US$ Million)
 Figure 92. Turkey PET Isotope Revenue (2020-2025) & (US$ Million)
 Figure 93. Egypt PET Isotope Revenue (2020-2025) & (US$ Million)
 Figure 94. South Africa PET Isotope Revenue (2020-2025) & (US$ Million)
 Figure 95. PET Isotope Industry Chain Mapping
 Figure 96. Regional PET Isotope Manufacturing Base Distribution (%)
 Figure 97. PET Isotope Production Process
 Figure 98. Regional PET Isotope Production Cost Structure
 Figure 99. Channels of Distribution (Direct Vs Distribution)
 Figure 100. Bottom-up and Top-down Approaches for This Report
 Figure 101. Data Triangulation
 Figure 102. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

RELATED REPORTS

Global Resorcinol Formaldehyde Adhesive Resin Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19T20220
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Low-Sludge Phosphating Solution Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33H20007
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Linear Alpha-Olefin Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5Y6896
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Nodulizer Cored Wire Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10G20315
Wed Dec 03 00:00:00 UTC 2025

Add to Cart